menu-iconMore mobile-close-icon
Skip Navigation
Skip Navigation
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 26   Next >
 
1.  
Atrial fibrillation: the management of atrial fibrillation. 2006 (revised 2014 Jun). NGC:010473
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
4.  
Antithrombotics: indications and management. A national clinical guideline. 1999 Mar (revised Aug 2012; republished 2013 Jun). NGC:009304
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation. 2012 Jun (revised 2013 Mar). NGC:009802
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
6.  
Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation. 2013 Feb. NGC:009629
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. 1998 Apr (revised 2013 Jan 22). NGC:009902
American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Professional Association; Heart Rhythm Society - Professional Association. View all guidelines by the developer(s)
8.  
9.  
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. 2012 Apr. NGC:009500
European Cardiac Arrhythmia Society - Disease Specific Society; European Heart Rhythm Association - Professional Association; Heart Rhythm Society - Professional Association. View all guidelines by the developer(s)
10.  
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. 2012 Mar. NGC:009077
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. 2005 (revised 2012 Jul). NGC:009543
European Society of Cardiology - Medical Specialty Society; Heart Failure Association of the ESC - Disease Specific Society. View all guidelines by the developer(s)
13.  
14.  
Guidelines on oral anticoagulation with warfarin - fourth edition. 2006 Feb (revised 2011 Aug). NGC:008814
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
15.  
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. 2011 Aug. NGC:009502
European Heart Rhythm Association - Professional Association; Heart Rhythm Society - Professional Association. View all guidelines by the developer(s)
16.  
Screening for cardiovascular disease and risk factors. 2011 Mar. NGC:009530
Singapore Ministry of Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Warfarin therapy management. 2010 Oct 1. NGC:008153
Medical Services Commission, British Columbia - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
Dronedarone for the treatment of non-permanent atrial fibrillation. 2010 Aug. NGC:008064
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
20.  
Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. 2014 May. NGC:010288
American Heart Association - Professional Association; American Stroke Association - Disease Specific Society. View all guidelines by the developer(s)
1-20 of 26   Next >